NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-143-2017-0-US-03 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range US National Stage 16/640,620 10994029 Issued PDF
NCATS E-050-2012-0-JP-14 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases JP DIV 2020-026808 Issued
NIAID E-020-2020-0-US-01 EPSTEIN-BARR VIRUS MONOCLONAL ANTIBODIES AND USES THEREOF US 62/979,070 Abandoned
NCI E-099-2014-0-EP-11 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF EP DIV 20158336.6 Issued
NIAID E-145-2011-0-AU-16 Plasmodial Surface Anion Channel Inhibitors For The Treatment Or Prevention Of Malaria AU DIV 2020201140 Issued
NEI E-057-2020-0-US-01 METHODS AND SYSTEMS FOR PREDICTING RATES OF PROGRESSION OF AGE-RELATED MACULAR DEGENERATION US 62/978,070 Abandoned
CC E-001-2019-1-EP-03 Handgrip Relaxometer Devices EP National Stage 20710721.0 Issued
CC E-001-2019-1-GB-01 Handgrip Relaxometer Devices GB EP 20710721.0 Issued
CC E-001-2019-1-DE-01 Handgrip Relaxometer Devices DE EP 20710721.0 Issued
CC E-001-2019-1-FR-01 Handgrip Relaxometer Devices FR EP 20710721.0 Issued
NHLBI E-175-2017-0-US-03 Hybrid CT System With Additional Detectors In Close Proximity To The Body US National Stage 16/639,469 1124-12-07 Issued PDF
CC E-001-2019-1-PCT-01 HANDGRIP RELAXOMETER SYSTEM PCT PCT COMB PCT/US2020/018273 Expired
NCI E-074-2020-0-US-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US 62/976,655 Abandoned
NCCIH E-081-2020-0-US-01 MARGARIC ACID DECREASES PIEZO2-MEDIATED PAIN US 62/976,014 Abandoned
NCI E-031-2020-0-US-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION US 62/975,544 Abandoned
NCI E-243-2015-0-US-05 ANTI-CD276 CHIMERIC ANTIGEN RECEPTORS US CON 16/788,895 Abandoned
NIAID E-147-2015-0-EP-14 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION EP DIV 20156778.1 Pending
NIAID E-086-2020-0-US-01 2019-nCoV VACCINE US 62/972,886 Abandoned
NCI E-053-2019-0-PCT-02 GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCs) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES PCT PCT PCT/US2020/017515 Expired
NIAID E-131-2015-2-US-09 lNEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE US CON 16/786,267 Abandoned
NCI E-171-2018-9-US-05 MODIFIED CELLS AND METHODS OF THERAPY US CON 16/786,013 Abandoned
NCI E-053-2019-0-CA-09 GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCs) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES CA National Stage 3128871 Pending
NIAID E-032-2019-0-KR-06 NANOPARTICLE-BASED INFLUENZA VIRUS VACCINES AND USES THEREOF KR National Stage 10-2021-7026196 Issued
NIAID E-032-2019-0-AU-03 Nanoparticle-based Influenza Virus Vaccines and Uses Thereof AU National Stage 2020219803 Issued
NIAID E-032-2019-0-PCT-02 NANOPARTICLE-BASED INFLUENZA VIRUS VACCINES AND USES THEREOF PCT PCT PCT/US2020/017216 Expired
NIAID E-032-2019-0-HK-08 NANOPARTICLE-BASED INFLUENZA VIRUS VACCINES AND USES THEREOF HK EP 62022053678.8 Pending
NIAID E-032-2019-0-CN-04 Adaptive Modular Nanoparticle-Based Universal Influenza Vaccine Platform CN National Stage 202080013357.7 Pending
NIAID E-032-2019-0-EP-05 NANOPARTICLE-BASED INFLUENZA VIRUS VACCINES AND USES THEREOF EP National Stage 20710367.2 Pending
NIAID E-182-2020-1-US-01 CORONAVIRUS RNA VACCINES US 62/971,825 Abandoned
NIA E-151-2017-0-KR-08 FATTY ACID DERIVATIVES AND THEIR USE KR National Stage 10-2020-7003568 Issued
NICHD E-014-2019-0-US-02 COMPOSITE GELS AND METHODS OF USE THEREOF US ORD 16/783,494 12083246 Issued PDF
NHLBI E-011-2016-0-US-03 CLOSED-ENDED, LINEAR, DUPLEX ADENOASSOCIATED VIRUS DNA, AND USES THEREOF US National Stage 16/637,152 11549125 Issued PDF
NEI E-165-2017-0-US-04 COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES US National Stage 16/636,945 11547708 Issued PDF
NIAID E-120-2001-1-AU-03 Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses AU DIV 2020200863 Expired
NIEHS E-210-2017-0-US-06 COMPOSITIONS AND METHODS FOR INHIBITING HIV-1 REVERSE TRANSCRIPTASE US National Stage 16/637,092 Abandoned
NIAID E-168-2020-0-US-01 Corona Virus Binders US 62/971,013 Expired
NCI E-750-2013-0-JP-20 Methods for Subtyping Lymphoma Types by Means of Expression Profiling JP DIV 2020-018323 Issued
NCI E-040-2012-0-JP-55 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen JP DIV 2020-018005 Issued
NIDDK E-064-2004-0-US-61 The Use Of Leptin For Treating Human Lipotrophy US CON 16/782,773 Abandoned
NCATS E-176-2018-0-US-01 TAT PEPTIDE BINDING PROTEINS AND USES THEREOF US 62/970,662 Abandoned
NCI E-094-2017-2-US-04 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment US CON 16/780,325 1197-05-28 Issued PDF
CC E-103-2018-0-EP-02 METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS EP National Stage 20708995.4 Issued
CC E-103-2018-0-GB-01 METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS GB EP 20708995.4 Issued
CC E-103-2018-0-DE-01 METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS DE EP 20708995.4 Issued
CC E-103-2018-0-DK-01 METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS DK EP 20708995.4 Issued
CC E-103-2018-0-FR-01 METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS FR EP 20708995.4 Issued
NCI E-190-2014-0-US-41 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS US CON 16/778,361 11110181 Issued PDF
NCI E-244-2015-0-US-11 BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE US DIV 16/778,043 11034740 Issued PDF
NCATS E-202-2016-4-US-04 Repurposing CDK Inhibitors For Treatment Of Zika Virus Infection US CON 16/779,132 10940188 Issued PDF
CC E-103-2018-0-PCT-01 METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS PCT PCT COMB PCT/US2020/016262 Expired